Clinical Trial Update: Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery [NA]

View source ↗

Summary

The clinical trial evaluating statin therapy to limit neurocognitive dysfunction after cardiac surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Dysfunction

Drugs mentioned

• Statin therapy (statin)

Snippet

Sponsor: Duke University | Conditions: Neurocognitive Dysfunction | NA | Status: WITHDRAWN